{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:24:28Z","timestamp":1793993068407,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013395","name":"Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014605","name":"Sage Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH101874"],"award-info":[{"award-number":["MH101874"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH114866"],"award-info":[{"award-number":["MH114866"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH122379"],"award-info":[{"award-number":["MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH123748"],"award-info":[{"award-number":["MH123748"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30DK020579"],"award-info":[{"award-number":["P30DK020579"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30DK056341"],"award-info":[{"award-number":["P30DK056341"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P41GM103422"],"award-info":[{"award-number":["P41GM103422"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopsych.2022.06.016","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T11:03:53Z","timestamp":1655895833000},"page":"964-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in the Adult Hippocampus"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5596-1031","authenticated-orcid":false,"given":"Yukitoshi","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong-Fu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nagele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Mennerick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Zorumski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2022.06.016_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fpsyt.2015.00172","article-title":"Treatment-resistant major depression: Rationale for NMDA receptors as targets and nitrous oxide as therapy","volume":"6","author":"Zorumski","year":"2015","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: When enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A\u00a0randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: A paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2022.06.016_bib5","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1523\/JNEUROSCI.1547-16.2016","article-title":"Ketamine: NMDA receptors and beyond","volume":"36","author":"Zorumski","year":"2016","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41467-019-13809-8","article-title":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","volume":"11","author":"Ali","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2022.06.016_bib7","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","article-title":"Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses","volume":"26","author":"Foga\u00e7a","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J\u00a0Clin Invest:"},{"key":"10.1016\/j.biopsych.2022.06.016_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104669","article-title":"Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents","volume":"134","author":"Ghosal","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2022.06.016_bib10","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib11","doi-asserted-by":"crossref","first-page":"E3007","DOI":"10.1073\/pnas.1718883115","article-title":"Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy","volume":"115","author":"Widman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2022.06.016_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2020.12.006","article-title":"Neurobiology of the rapid-acting antidepressant effects of ketamine: Impact and opportunities","volume":"90","author":"Shinohara","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2022.06.016_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TrkB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2022.06.016_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor signaling in depression and antidepressant action","volume":"90","author":"Castr\u00e9n","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: From synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2022.06.016_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2022.06.016_bib18","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-hydroxynorketamine exerts mGLu2 receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2022.06.016_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2022.06.016_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm0498-460","article-title":"Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin","volume":"4","author":"Jevtovi\u0107-Todorovi\u0107","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2022.06.016_bib21","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1523\/JNEUROSCI.18-23-09716.1998","article-title":"Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures","volume":"18","author":"Mennerick","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biopsych.2014.11.016","article-title":"Nitrous oxide for treatment-resistant major depression: A proof-of-concept trial","volume":"78","author":"Nagele","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe1376","article-title":"A\u00a0phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression","volume":"13","author":"Nagele","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2022.06.016_bib24","doi-asserted-by":"crossref","first-page":"16788","DOI":"10.1523\/JNEUROSCI.4101-10.2010","article-title":"Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis","volume":"30","author":"Tokuda","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000542-200501000-00034","article-title":"Nitrous oxide (laughing gas) facilitates excitability in rat hippocampal slices through \u03b3-aminobutyric acid A receptor-mediated disinhibition","volume":"102","author":"Nagashima","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2022.06.016_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuroscience.2005.08.002","article-title":"Acute effects of ethanol on hippocampal long-term potentiation and long-term depression are mediated by different mechanisms","volume":"136","author":"Izumi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2022.06.016_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuropharm.2014.08.002","article-title":"Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function","volume":"86","author":"Izumi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2022.06.016_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104875","article-title":"Inhibitors of cellular stress overcome acute effects of ethanol on hippocampal plasticity and learning","volume":"141","author":"Izumi","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2022.06.016_bib29","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1523\/JNEUROSCI.4998-12.2013","article-title":"Acute suppression of spontaneous neurotransmission drives synaptic potentiation","volume":"33","author":"Nosyreva","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-9236(95)90194-9","article-title":"Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers","volume":"58","author":"Hartvig","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2022.06.016_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnmol.2014.00094","article-title":"Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade","volume":"7","author":"Nosyreva","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.biopsych.2022.06.016_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.2899909","article-title":"Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists","volume":"241","author":"Honor\u00e9","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2022.06.016_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","article-title":"Targeting homeostatic synaptic plasticity for treatment of mood disorders","volume":"106","author":"Kavalali","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2022.06.016_bib34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/ALN.0b013e318219524e","article-title":"Anesthetic ketamine impairs rats\u2019 recall of previous information: The nitric oxide synthase inhibitor N-nitro-L-arginine methylester antagonizes this ketamine-induced recognition memory deficit","volume":"114","author":"Boultadakis","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2022.06.016_bib35","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1172\/JCI43992","article-title":"Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice","volume":"121","author":"Cazorla","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2022.06.016_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009777","article-title":"Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice","volume":"5","author":"Cazorla","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2022.06.016_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: Insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biopsych.2022.06.016_bib38","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1158\/0008-5472.CAN-05-4510","article-title":"Regulation of microtubule-dependent protein transport by the TSC2\/mammalian target of rapamycin pathway","volume":"66","author":"Jiang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopsych.2022.06.016_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2344\/0003-3006(2007)54[9:AIUTAO]2.0.CO;2","article-title":"Advances in understanding the actions of nitrous oxide","volume":"54","author":"Emmanouil","year":"2007","journal-title":"Anesth Prog"},{"key":"10.1016\/j.biopsych.2022.06.016_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biopsych.2015.04.007","article-title":"Potential pathways involved in the rapid antidepressant effects of nitrous oxide","volume":"78","author":"Zarate","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1476-5381.1993.tb13795.x","article-title":"Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects","volume":"110","author":"Moore","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2022.06.016_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: A randomized midazolam-controlled trial","volume":"178","author":"Dwyer","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/acel.12313","article-title":"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins","volume":"14","author":"Schreiber","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopsych.2022.06.016_bib44","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.06.016_bib45","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1038\/s41598-017-08166-9","article-title":"Isoflurane produces antidepressant effects and induces TrkB signaling in rodents","volume":"7","author":"Antila","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.06.016_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235046","article-title":"Lack of antidepressant effects of burst-suppressing isoflurane anesthesia in adult male Wistar outbred rats subjected to chronic mild stress","volume":"15","author":"Theilmann","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2022.06.016_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0091-3057(94)90333-6","article-title":"Involvement of nitric oxide in nitrous oxide anxiolysis in the elevated plus-maze","volume":"48","author":"Caton","year":"1994","journal-title":"Biochem Behav"},{"key":"10.1016\/j.biopsych.2022.06.016_bib48","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fpsyt.2020.00837","article-title":"Repeated nitrous oxide exposure exerts antidepressant-like effects through neuronal nitric oxide synthase activation in the medial prefrontal cortex","volume":"11","author":"Liu","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0006-2952(93)90484-E","article-title":"Nitric oxide and hippocampal synaptic plasticity","volume":"46","author":"Zorumski","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2022.06.016_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.neubiorev.2011.12.011","article-title":"NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders","volume":"36","author":"Zorumski","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2022.06.016_bib51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpsychires.2021.02.058","article-title":"The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review","volume":"137","author":"Di Vincenzo","year":"2021","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2022.06.016_bib53","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2022.06.016_bib55","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","article-title":"Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia?","volume":"38","author":"Farber","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.06.016_bib56","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.biopsych.2022.06.016_bib57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/JCP.0000000000000837","article-title":"Exploring nitrous oxide as treatment of mood disorders: Basic concepts","volume":"38","author":"Nagele","year":"2018","journal-title":"J\u00a0Clin Psychopharmacol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322013658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322013658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:08:37Z","timestamp":1762099717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322322013658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0006322322013658"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.06.016","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in the Adult Hippocampus","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}